However, the addition of FGF21/adiponectin ratio to Model 1 resulted in a significant improvement in predicting new-onset diabetes, with increments in NRI (27.1%, p < 0.001) and IDI (0.7%, p = 0.020). The gene discussed is ADIPOQ; the disease is diabetes mellitus.